Delivery Order 36C24224D0048-36C24225N0335

Award Date 1/7/25
Potential Completion Date 8/31/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT) to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The award, Contract ID 36C24224D0048|36C24225N0194, has a ceiling value of $6,874.38 and is a Firm Fixed Price Delivery Order with an ultimate completion date of...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is a delivery order with a firm fixed price of $22,914.60 and a period of performance ending on December 31, 2024. The contract is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to the Department of Veterans Affairs (VA), specifically the VA Integrated Service Network 2 (VISN 2). RLS (USA) Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles...
This contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of NETSPOT GA-68 radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $2,291.46 firm-fixed price contract has an ultimate completion date of August 21, 2024. RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency to facilitate the efficient procurement of its radiopharmaceutical products, including...
This federal contract award was issued by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is a Blanket Purchase Agreement (BPA) call for the procurement of 16 units of Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical product critical for nuclear medicine imaging procedures. The award has a ceiling value of $48,000.00 and a firm-fixed-price type. RLS (USA) Inc. is an established supplier of radiopharmaceuticals to the...
This federal contract award was made by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the delivery of Netspot (Gallium-68 Dotatate), a radiopharmaceutical used in nuclear medicine diagnostic procedures. The contract has a ceiling value of $21,000.00 and a completion date of October 13, 2023. RLS (USA) Inc. is the prime contractor for this firm fixed-price contract, which is a blanket purchase agreement (BPA) call. The...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of NETSPOT GA-68, a radiopharmaceutical used in nuclear medicine diagnostic services. The contract has a ceiling value of $18,331.68 and a performance period ending on August 31, 2025. RLS (USA) Inc. is registered in the System for Award Management (SAM) and qualifies as a small business. The company...
This federal contract award, valued at $75,489.81, was issued by the Department of Veterans Affairs' Greater Los Angeles Healthcare System to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the delivery of Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical used in nuclear medicine imaging procedures, to the VA facility in Los Angeles, California. The contract was awarded as a firm-fixed-price purchase order with a period of performance from January 3, 2024...
This is a delivery order contract awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of NETSPOT GA-68, a radiopharmaceutical product used in nuclear medicine imaging procedures. The delivery order has a firm fixed price ceiling value of $43,537.74 and a performance period that runs through August 31, 2025. RLS (USA) Inc. is...
This federal contract award was issued by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a for-profit radiopharmacy company. The $13,748.76 firm fixed-price delivery order is for the supply of NETSPOT GA-68, a radiopharmaceutical product used in nuclear medicine diagnostic services, during the period of September 1, 2025 to December 31, 2025. RLS (USA) Inc. is the prime contractor for this award, which was not...
This federal contract award was issued by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of 5-NETSPOT Gallium-68 Dotatate, a radiopharmaceutical product used in nuclear medicine imaging procedures. The contract is a Blanket Purchase Agreement (BPA) call, with a firm-fixed price of $15,000.00 and a period of performance ending on October 20, 2022. RLS (USA) Inc. is a small business that specializes in providing...
  • 36C24224D0048
    Indefinite Delivery Contract
  • 36C24224D0048-36C24225N0335
    Delivery Order

This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of radiopharmaceuticals such as Gallium-68 Dotatate (NETSPOT) to the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $27,497.52 firm fixed-price delivery order has an ultimate completion date of August 31, 2025 and is not set-aside. RLS (USA) Inc. is a small business that holds several indefinite delivery vehicle (IDV) contracts with the VA and DHA, including a $4,998,603.38 contract with VA VISN 17 for radiopharmaceuticals, a $538,493.10 small business set-aside contract with VA VISN 2 for Netspot, and a $1,914,116.40 contract with the DHA for general radiopharmaceuticals. These IDVs enable RLS (USA) Inc. to provide consistent, on-demand radiopharmaceutical supplies to support federal healthcare facilities' nuclear medicine programs.

Generated 1/9/25, 9:30 AM